Oruka Therapeutics Raises $700 Million in Upsized Public Offering—Capital Infusion Fuels Ambitious Pipeline Expansion
Market Chameleon (Wed, 29-Apr 8:00 AM)
Upcoming ORKA-001 Data Release Draws Attention Ahead of EVERLAST-A Trial Results
Market Chameleon (Mon, 27-Apr 10:31 AM)
ORKA-001 Delivers High Rate of Skin Clearance at Week 16, Suggests Potential for Once-Yearly Psoriasis Treatment
Market Chameleon (Mon, 27-Apr 7:29 AM)
